EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Y12C mutation disrupts IMPDH cytoophidia and alters cancer metabolism

Chia-Chun Chang iD, Min Peng iD, Gerson Dierley Keppeke iD, Li-Kuang Tsai iD, Ziheng Zhang iD, Li-Mei Pai iD, Li-Ying Sung iD, Ji-Long Liu iD

The FEBS Journal · 2025-07 · 292 (14) · 3676-3695

DOI: 10.1111/febs.70086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, online erschienen am 05.04.2025. Verfasst von Chia-Chun Chang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biotechnology, National Taiwan University, Taipei, Taiwan. Hauptthemen laut MEDLINE: IMP Dehydrogenase, Neoplasms, Guanosine Triphosphate. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Guanosine triphosphate (GTP) is a building block for DNA and RNA, and plays a pivotal role in various cellular functions, serving as an energy source, enzyme cofactor and a key component of signal transduction. The activity of the rate‐limiting enzyme in de novo GTP synthesis, inosine monophosphate dehydrogenase (IMPDH), is regulated by nucleotide binding. Recent studies have illuminated that IMPDH octamers can assemble into linear polymers, adding another dimension to its enzymatic regulation. This polymerisation reduces IMPDH's sensitivity to the inhibitory effects of GTP binding, thereby augmenting its activity under conditions with elevated GTP levels. Within cells, IMPDH polymers may cluster to form the distinctive structure known as the cytoophidium, which is postulated to reflect the cellular demand for increased GTP concentrations. Nevertheless, the functional significance of IMPDH polymerisation in in vivo metabolic regulation remains unclear. In this study, we report the widespread presence of IMPDH cytoophidia in various human cancer tissues. Utilising the ABEmax base editor, we introduced a Y12C point mutation into IMPDH2 across multiple cancer cell lines. This mutation disrupts the polymerisation interface of IMPDH and prevents cytoophidium assembly. In some cancer xenografts, the absence of IMPDH polymers led to a downregulation of IMPDH , as well as the glycolytic and pentose phosphate pathways. Furthermore, mutant HeLa‐cell‐derived xenografts were notably smaller than their wild‐type counterparts. Our data suggest that IMPDH polymerisation and cytoophidium assembly could be instrumental in modulating metabolic homeostasis in certain cancers, offering insights into the clinical relevance of IMPDH cytoophidium.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IMP DehydrogenaseNeoplasmsGuanosine TriphosphateHumansAnimalsMiceCell Line, Tumor

Stichwörter der Autor:innen

CRISPR base editorIMPDHcancercytoophidiumglycolysispentose phosphate pathway

Substanzen

IMP DehydrogenaseGuanosine TriphosphateIMPDH2 protein, human

Autor:innen und Institutionen

  • Institute of Biotechnology, National Taiwan University, Taipei, Taiwan.
  • School of Life Science and Technology, ShanghaiTech University, China.
  • Departamento de Ciencias Biomédicas, Facultad de Medicina, Universidad Católica del Norte, Coquimbo, Chile.
  • Department of Biochemistry and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Liver Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Center for Developmental Biology and Regenerative Medicine, National Taiwan University, Taipei, Taiwan.

ORCID-Profile: Chia-Chun Chang, Min Peng, Gerson Dierley Keppeke, Li-Kuang Tsai, Ziheng Zhang, Li-Mei Pai, Li-Ying Sung, Ji-Long Liu

Förderung

  • National Science and Technology Council
  • Ministry of Science and Technology of the People's Republic of China
  • National Natural Science Foundation of China
  • Medical Research Council

Zitieren

APA

Chang, C. C., Peng, M., Keppeke, G. D., Tsai, L. K., Zhang, Z., Pai, L. M., Sung, L. Y., & Liu, J. L. (2025). Y12C mutation disrupts IMPDH cytoophidia and alters cancer metabolism. The FEBS Journal, 292(14), 3676-3695. https://doi.org/10.1111/febs.70086

Vancouver

Chang CC, Peng M, Keppeke GD, Tsai LK, Zhang Z, Pai LM, et al. Y12C mutation disrupts IMPDH cytoophidia and alters cancer metabolism. The FEBS Journal. 2025;292(14):3676-3695. doi:10.1111/febs.70086

BibTeX
@article{Chang2025,
  author = {Chang, Chia-Chun and Peng, Min and Keppeke, Gerson Dierley and Tsai, Li-Kuang and Zhang, Ziheng and Pai, Li-Mei and Sung, Li-Ying and Liu, Ji-Long},
  title = {Y12C mutation disrupts IMPDH cytoophidia and alters cancer metabolism},
  journal = {The FEBS Journal},
  year = {2025},
  volume = {292},
  number = {14},
  pages = {3676--3695},
  doi = {10.1111/febs.70086}
}
Kostenlos starten →